Literature DB >> 15050788

Inhibitory control in Obsessive-Compulsive Disorder.

Robert Krikorian1, Molly E Zimmerman, David E Fleck.   

Abstract

The clinical features of Obsessive-Compulsive Disorder (OCD) suggest that a fundamental deficit of inhibitory control is intrinsic to the disorder. In this preliminary study, we sought to examine cognitive disinhibition in OCD by using an established laboratory technique. The stop signal task was administered to a higher functioning, untreated group of individuals with OCD, and to healthy comparison participants. Surprisingly, the OCD participants exhibited more accurate performance, suggesting better inhibitory control on this task. This unexpected finding suggests that higher functioning individuals with OCD are capable of adequate inhibition in certain contexts. It was speculated, however, that emotional stimulation might negatively affect performance and that this might be studied in subsequent research.

Entities:  

Mesh:

Year:  2004        PMID: 15050788     DOI: 10.1016/j.bandc.2004.02.038

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  14 in total

1.  Impact of orbitofrontal lesions on electrophysiological signals in a stop signal task.

Authors:  Anne-Kristin Solbakk; Ingrid Funderud; Marianne Løvstad; Tor Endestad; Torstein Meling; Magnus Lindgren; Robert T Knight; Ulrike M Krämer
Journal:  J Cogn Neurosci       Date:  2014-01-06       Impact factor: 3.225

2.  Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.

Authors:  Daniel O Claassen; Wery P M van den Wildenberg; Madaline B Harrison; Nelleke C van Wouwe; Kristen Kanoff; Joseph S Neimat; Scott A Wylie
Journal:  Pharmacol Biochem Behav       Date:  2014-11-29       Impact factor: 3.533

3.  Exposure to emotionally arousing, contamination-relevant pictorial stimuli interferes with response inhibition: Implication for obsessive-compulsive disorder.

Authors:  Thomas G Adams
Journal:  J Obsessive Compuls Relat Disord       Date:  2015-05-22       Impact factor: 1.677

4.  Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.

Authors:  Silvia Picazio; Viviana Ponzo; Carlo Caltagirone; Livia Brusa; Giacomo Koch
Journal:  J Neurol       Date:  2018-07-06       Impact factor: 4.849

5.  Dietary ketosis enhances memory in mild cognitive impairment.

Authors:  Robert Krikorian; Marcelle D Shidler; Krista Dangelo; Sarah C Couch; Stephen C Benoit; Deborah J Clegg
Journal:  Neurobiol Aging       Date:  2010-12-03       Impact factor: 4.673

6.  Cool and Hot Aspects of Executive Function in Childhood Obsessive-Compulsive Disorder.

Authors:  Katja Anna Hybel; Erik Lykke Mortensen; Rikke Lambek; Mikael Thastum; Per Hove Thomsen
Journal:  J Abnorm Child Psychol       Date:  2017-08

7.  Enhanced neural activation with blueberry supplementation in mild cognitive impairment.

Authors:  Erin L Boespflug; James C Eliassen; Jonathan A Dudley; Marcelle D Shidler; Wilhelmina Kalt; Suzanne S Summer; Amanda L Stein; Amanda N Stover; Robert Krikorian
Journal:  Nutr Neurosci       Date:  2017-02-21       Impact factor: 4.994

8.  Obsessive-compulsive disorder is associated with broad impairments in executive function: A meta-analysis.

Authors:  Hannah R Snyder; Roselinde H Kaiser; Stacie L Warren; Wendy Heller
Journal:  Clin Psychol Sci       Date:  2015-03

9.  Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment.

Authors:  Robert K McNamara; Wilhelmina Kalt; Marcelle D Shidler; Jane McDonald; Suzanne S Summer; Amanda L Stein; Amanda N Stover; Robert Krikorian
Journal:  Neurobiol Aging       Date:  2017-12-12       Impact factor: 4.673

10.  Blueberry supplementation improves memory in older adults.

Authors:  Robert Krikorian; Marcelle D Shidler; Tiffany A Nash; Wilhelmina Kalt; Melinda R Vinqvist-Tymchuk; Barbara Shukitt-Hale; James A Joseph
Journal:  J Agric Food Chem       Date:  2010-04-14       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.